Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2006-05-18 09:04:45 UTC |
---|
Update Date | 2022-03-07 02:49:11 UTC |
---|
HMDB ID | HMDB0001939 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Medroxyprogesterone |
---|
Description | Medroxyprogesterone, or MP is a progestin (synthetic progestogen). MP is not used medically, as it is over two orders of magnitude less potent than medroxyprogesterone acetate (MPA); a derivative of MP (PMID: 16784762 ). MP may be formed via the metabolism of MPA. Medroxyprogesterone acetate is used to treat conditions such as absent or irregular menstrual periods, or abnormal uterine bleeding. Synthetic progestogens are widely used to simulate the effects of progesterone; a natural female sex hormone. Progesterone is essential for endometrial receptivity, embryo implantation, and the successful establishment of pregnancy. A low progesterone concentration or an insufficient response to progesterone can cause infertility and pregnancy loss (PMID: 20104424 ). In addition to progestagenic activity, MP is also a weak antiandrogen in vitro (PMID: 29990947 ). Medroxyprogesterone is only found in individuals that have used or taken MPA. |
---|
Structure | [H][C@@]12CC[C@](O)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)CC[C@]12C InChI=1S/C22H32O3/c1-13-11-16-17(20(3)8-5-15(24)12-19(13)20)6-9-21(4)18(16)7-10-22(21,25)14(2)23/h12-13,16-18,25H,5-11H2,1-4H3/t13-,16+,17-,18-,20+,21-,22-/m0/s1 |
---|
Synonyms | Value | Source |
---|
17-Hydroxy-6alpha-methyl-pregn-4-ene-3,20-dione | ChEBI | 17-Hydroxy-6alpha-methylprogesterone | ChEBI | 17alpha-Hydroxy-6alpha-methylprogesterone | ChEBI | 6alpha-Methyl-17alpha-hydroxyprogesterone | ChEBI | 6alpha-Methyl-4-pregnen-17alpha-ol-3,20-dione | ChEBI | Medroxiprogesterona | ChEBI | Medroxyprogesteron | ChEBI | Medroxyprogesteronum | ChEBI | Farlutal inyectable | Kegg | 17-Hydroxy-6a-methyl-pregn-4-ene-3,20-dione | Generator | 17-Hydroxy-6α-methyl-pregn-4-ene-3,20-dione | Generator | 17-Hydroxy-6a-methylprogesterone | Generator | 17-Hydroxy-6α-methylprogesterone | Generator | 17a-Hydroxy-6a-methylprogesterone | Generator | 17Α-hydroxy-6α-methylprogesterone | Generator | 6a-Methyl-17a-hydroxyprogesterone | Generator | 6Α-methyl-17α-hydroxyprogesterone | Generator | 6a-Methyl-4-pregnen-17a-ol-3,20-dione | Generator | 6Α-methyl-4-pregnen-17α-ol-3,20-dione | Generator | Cycrin | HMDB | Depo-provera | HMDB | Depo-subq provera 104 | HMDB | Farlutal | HMDB | Medrossiprogesterone | HMDB | Medroxiprogesteronum | HMDB | Medroxyprogesterone acetate | HMDB | Provera | HMDB | 17 alpha Hydroxy 6 alpha methylprogesterone | HMDB | Medroxyprogesterone strakan brand | HMDB | Strakan brand OF medroxyprogesterone | HMDB | 17 alpha-Hydroxy-6 alpha-methylprogesterone | HMDB | Adgyn medro | HMDB | Methylhydroxyprogesterone | HMDB |
| Show more...
---|
Chemical Formula | C22H32O3 |
---|
Average Molecular Weight | 344.4877 |
---|
Monoisotopic Molecular Weight | 344.23514489 |
---|
IUPAC Name | (1S,2R,8S,10R,11S,14R,15S)-14-acetyl-14-hydroxy-2,8,15-trimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one |
---|
Traditional Name | (1S,2R,8S,10R,11S,14R,15S)-14-acetyl-14-hydroxy-2,8,15-trimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one |
---|
CAS Registry Number | 520-85-4 |
---|
SMILES | [H][C@@]12CC[C@](O)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)CC[C@]12C |
---|
InChI Identifier | InChI=1S/C22H32O3/c1-13-11-16-17(20(3)8-5-15(24)12-19(13)20)6-9-21(4)18(16)7-10-22(21,25)14(2)23/h12-13,16-18,25H,5-11H2,1-4H3/t13-,16+,17-,18-,20+,21-,22-/m0/s1 |
---|
InChI Key | FRQMUZJSZHZSGN-HBNHAYAOSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as gluco/mineralocorticoids, progestogins and derivatives. These are steroids with a structure based on a hydroxylated prostane moiety. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Steroids and steroid derivatives |
---|
Sub Class | Pregnane steroids |
---|
Direct Parent | Gluco/mineralocorticoids, progestogins and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Progestogin-skeleton
- 20-oxosteroid
- 3-oxo-delta-4-steroid
- 3-oxosteroid
- 17-hydroxysteroid
- Oxosteroid
- Hydroxysteroid
- Delta-4-steroid
- Cyclohexenone
- Alpha-hydroxy ketone
- Cyclic alcohol
- Tertiary alcohol
- Cyclic ketone
- Ketone
- Organic oxygen compound
- Carbonyl group
- Hydrocarbon derivative
- Alcohol
- Organooxygen compound
- Organic oxide
- Aliphatic homopolycyclic compound
|
---|
Molecular Framework | Aliphatic homopolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 214.5 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Medroxyprogesterone,1TMS,isomer #1 | CC(=O)[C@@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C | 3046.1 | Semi standard non polar | 33892256 | Medroxyprogesterone,1TMS,isomer #2 | CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(O[Si](C)(C)C)=CC[C@]4(C)[C@H]3CC[C@@]21C | 2931.1 | Semi standard non polar | 33892256 | Medroxyprogesterone,1TMS,isomer #3 | C=C(O[Si](C)(C)C)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C | 2949.4 | Semi standard non polar | 33892256 | Medroxyprogesterone,2TMS,isomer #1 | CC(=O)[C@@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(O[Si](C)(C)C)=CC[C@]4(C)[C@H]3CC[C@@]21C | 2950.2 | Semi standard non polar | 33892256 | Medroxyprogesterone,2TMS,isomer #1 | CC(=O)[C@@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(O[Si](C)(C)C)=CC[C@]4(C)[C@H]3CC[C@@]21C | 2908.1 | Standard non polar | 33892256 | Medroxyprogesterone,2TMS,isomer #1 | CC(=O)[C@@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(O[Si](C)(C)C)=CC[C@]4(C)[C@H]3CC[C@@]21C | 3232.6 | Standard polar | 33892256 | Medroxyprogesterone,2TMS,isomer #2 | C=C(O[Si](C)(C)C)[C@@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C | 2995.1 | Semi standard non polar | 33892256 | Medroxyprogesterone,2TMS,isomer #2 | C=C(O[Si](C)(C)C)[C@@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C | 2867.7 | Standard non polar | 33892256 | Medroxyprogesterone,2TMS,isomer #2 | C=C(O[Si](C)(C)C)[C@@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C | 3296.4 | Standard polar | 33892256 | Medroxyprogesterone,2TMS,isomer #3 | C=C(O[Si](C)(C)C)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(O[Si](C)(C)C)=CC[C@]4(C)[C@H]3CC[C@@]21C | 2870.7 | Semi standard non polar | 33892256 | Medroxyprogesterone,2TMS,isomer #3 | C=C(O[Si](C)(C)C)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(O[Si](C)(C)C)=CC[C@]4(C)[C@H]3CC[C@@]21C | 2861.2 | Standard non polar | 33892256 | Medroxyprogesterone,2TMS,isomer #3 | C=C(O[Si](C)(C)C)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(O[Si](C)(C)C)=CC[C@]4(C)[C@H]3CC[C@@]21C | 3348.5 | Standard polar | 33892256 | Medroxyprogesterone,3TMS,isomer #1 | C=C(O[Si](C)(C)C)[C@@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(O[Si](C)(C)C)=CC[C@]4(C)[C@H]3CC[C@@]21C | 2886.9 | Semi standard non polar | 33892256 | Medroxyprogesterone,3TMS,isomer #1 | C=C(O[Si](C)(C)C)[C@@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(O[Si](C)(C)C)=CC[C@]4(C)[C@H]3CC[C@@]21C | 2936.6 | Standard non polar | 33892256 | Medroxyprogesterone,3TMS,isomer #1 | C=C(O[Si](C)(C)C)[C@@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(O[Si](C)(C)C)=CC[C@]4(C)[C@H]3CC[C@@]21C | 3274.8 | Standard polar | 33892256 | Medroxyprogesterone,1TBDMS,isomer #1 | CC(=O)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C | 3276.6 | Semi standard non polar | 33892256 | Medroxyprogesterone,1TBDMS,isomer #2 | CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3CC[C@@]21C | 3192.7 | Semi standard non polar | 33892256 | Medroxyprogesterone,1TBDMS,isomer #3 | C=C(O[Si](C)(C)C(C)(C)C)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C | 3210.6 | Semi standard non polar | 33892256 | Medroxyprogesterone,2TBDMS,isomer #1 | CC(=O)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3CC[C@@]21C | 3467.5 | Semi standard non polar | 33892256 | Medroxyprogesterone,2TBDMS,isomer #1 | CC(=O)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3CC[C@@]21C | 3375.9 | Standard non polar | 33892256 | Medroxyprogesterone,2TBDMS,isomer #1 | CC(=O)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3CC[C@@]21C | 3446.5 | Standard polar | 33892256 | Medroxyprogesterone,2TBDMS,isomer #2 | C=C(O[Si](C)(C)C(C)(C)C)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C | 3500.0 | Semi standard non polar | 33892256 | Medroxyprogesterone,2TBDMS,isomer #2 | C=C(O[Si](C)(C)C(C)(C)C)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C | 3371.2 | Standard non polar | 33892256 | Medroxyprogesterone,2TBDMS,isomer #2 | C=C(O[Si](C)(C)C(C)(C)C)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C | 3501.9 | Standard polar | 33892256 | Medroxyprogesterone,2TBDMS,isomer #3 | C=C(O[Si](C)(C)C(C)(C)C)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3CC[C@@]21C | 3370.3 | Semi standard non polar | 33892256 | Medroxyprogesterone,2TBDMS,isomer #3 | C=C(O[Si](C)(C)C(C)(C)C)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3CC[C@@]21C | 3314.1 | Standard non polar | 33892256 | Medroxyprogesterone,2TBDMS,isomer #3 | C=C(O[Si](C)(C)C(C)(C)C)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3CC[C@@]21C | 3564.4 | Standard polar | 33892256 | Medroxyprogesterone,3TBDMS,isomer #1 | C=C(O[Si](C)(C)C(C)(C)C)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3CC[C@@]21C | 3626.1 | Semi standard non polar | 33892256 | Medroxyprogesterone,3TBDMS,isomer #1 | C=C(O[Si](C)(C)C(C)(C)C)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3CC[C@@]21C | 3581.6 | Standard non polar | 33892256 | Medroxyprogesterone,3TBDMS,isomer #1 | C=C(O[Si](C)(C)C(C)(C)C)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3CC[C@@]21C | 3517.1 | Standard polar | 33892256 |
| Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Medroxyprogesterone GC-MS (Non-derivatized) - 70eV, Positive | splash10-00tf-4297000000-cd7180f050ed3c53c6ef | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Medroxyprogesterone GC-MS (1 TMS) - 70eV, Positive | splash10-0uki-2297500000-c6975631306bc23561a4 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Medroxyprogesterone GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Medroxyprogesterone GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Medroxyprogesterone Quattro_QQQ 10V, N/A-QTOF (Annotated) | splash10-000i-1339000000-b79365e841d4bec0f180 | 2012-07-25 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Medroxyprogesterone Quattro_QQQ 25V, N/A-QTOF (Annotated) | splash10-00dj-3910000000-9983023f32301e1fba4f | 2012-07-25 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Medroxyprogesterone Quattro_QQQ 40V, N/A-QTOF (Annotated) | splash10-00dj-8900000000-79ac294ddbd774821e12 | 2012-07-25 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Medroxyprogesterone LC-ESI-qTof , Positive-QTOF | splash10-0002-0319000000-a0d745584bc883eda4a8 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Medroxyprogesterone , positive-QTOF | splash10-0002-0319000000-a0d745584bc883eda4a8 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Medroxyprogesterone , positive-QTOF | splash10-00di-4931000000-13a32e65d38099780615 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Medroxyprogesterone 20V, Positive-QTOF | splash10-0002-0219000000-053fe09f5f581304e489 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Medroxyprogesterone 30V, Positive-QTOF | splash10-00di-0931000000-cf29ab5c482da194c793 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Medroxyprogesterone 10V, Positive-QTOF | splash10-0002-0009000000-dce8dfd249bbc8536b02 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Medroxyprogesterone 35V, Positive-QTOF | splash10-006t-2926000000-27ffccce12006e18344a | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Medroxyprogesterone 40V, Positive-QTOF | splash10-00di-0910000000-b3401643e191b15ec5c0 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Medroxyprogesterone 50V, Positive-QTOF | splash10-00di-0900000000-e3c170bb53acd6540911 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Medroxyprogesterone 35V, Positive-QTOF | splash10-006t-3907000000-e2ef8aee0b8ef98652d6 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Medroxyprogesterone 20V, Negative-QTOF | splash10-0002-0097000000-9c484cc7f2b792d00c25 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Medroxyprogesterone 10V, Negative-QTOF | splash10-0006-0019000000-435bcb637366453b98bd | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Medroxyprogesterone 20V, Positive-QTOF | splash10-0002-0209000000-8f976444cc5262c1c92c | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Medroxyprogesterone 50V, Positive-QTOF | splash10-00di-0900000000-0b0c65efe5b7c9520650 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Medroxyprogesterone 30V, Negative-QTOF | splash10-0002-0096000000-c57e97b64656d5c2454b | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Medroxyprogesterone 40V, Negative-QTOF | splash10-0002-0090000000-e6ace08882d55359ec8d | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Medroxyprogesterone 10V, Positive-QTOF | splash10-0002-0009000000-860975266cd1b971e6ab | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Medroxyprogesterone 20V, Positive-QTOF | splash10-0fvj-0189000000-ec97befb496198e1f69f | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Medroxyprogesterone 40V, Positive-QTOF | splash10-0udr-1691000000-2eabdaeb463f59c27177 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Medroxyprogesterone 10V, Negative-QTOF | splash10-0006-0009000000-eabfc17143af207764c8 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Medroxyprogesterone 20V, Negative-QTOF | splash10-0f6x-0029000000-3cbdd488660baed87ee9 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Medroxyprogesterone 40V, Negative-QTOF | splash10-00g0-0094000000-1cee9f40fb0d5cf31715 | 2017-09-01 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Experimental 1D NMR | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | 2012-12-05 | Wishart Lab | View Spectrum | Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | 2012-12-05 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | - Extracellular
- Membrane (predicted from logP)
|
---|
Biospecimen Locations | Not Available |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| Not Available |
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB022754 |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 10185 |
---|
KEGG Compound ID | C07119 |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Medroxyprogesterone |
---|
METLIN ID | 1094 |
---|
PubChem Compound | 10631 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 6715 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Pullen MA, Laping N, Edwards R, Bray J: Determination of conformational changes in the progesterone receptor using ELISA-like assays. Steroids. 2006 Sep;71(9):792-8. doi: 10.1016/j.steroids.2006.05.009. Epub 2006 Jun 19. [PubMed:16784762 ]
- Young SL, Lessey BA: Progesterone function in human endometrium: clinical perspectives. Semin Reprod Med. 2010 Jan;28(1):5-16. doi: 10.1055/s-0029-1242988. Epub 2010 Jan 26. [PubMed:20104424 ]
- Sauer P, Borik A, Golovko O, Grabic R, Stanova AV, Valentova O, Stara A, Sandova M, Kocour Kroupova H: Do progestins contribute to (anti-)androgenic activities in aquatic environments? Environ Pollut. 2018 Nov;242(Pt A):417-425. doi: 10.1016/j.envpol.2018.06.104. Epub 2018 Jul 4. [PubMed:29990947 ]
|
---|